carboxymethyl-hexanoyl chitosan

structure in first source

Networked: 5 relevant articles (1 outcomes, 3 trials/studies)

1.	Liver Failure 02/01/2015 - "Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model."
2.	Osteosarcoma (Osteogenic Sarcoma) 01/01/2021 - "In this study, we developed an innovative method for treating osteosarcoma by using a novel radiation-enhancer (i.e., carboxymethyl-hexanoyl chitosan-coated self-assembled Au@Fe3O4 nanoparticles; CSAF NPs). " 01/01/2020 - "This study demonstrated a novel injectable-thermoreversible hydrogel scaffold composing of PLuronic F127, carboxymethyl hexanoyl chitosan (CA) and glyoxal (Gx) for encapsulating human osteosarcoma MG-63 cells. "
3.	Neoplasms (Cancer) 01/01/2018 - "Carboxymethyl-hexanoyl Chitosan Nanodroplets for Ultrasonic Imaging and Drug Delivery to Tumor." 08/01/2014 - "In the present study, a new bubble-forming material (carboxymethyl hexanoyl chitosan, CHC), together with superparamagnetic iron oxide (SPIO) nanoparticles, was employed to prepare image-guided bubbles for efficiently encapsulating and delivering hydrophobic agents to kill tumor cells. "

1.	Polyurethanes (Polyurethane)
2.	Poloxamer (Poloxamer 407)
3.	Hydrogels
4.	Glyoxal (Ethanedial)
5.	ferric oxide (iron oxide)